Biotech entity
Every one of those 1 sits in a single category, pharma. Sargassum is most often covered alongside Artificial Intelligence, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window.
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Sargassum is most often covered alongside Artificial Intelligence, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. The average consequence score is 6, matching the 6 beat baseline for this window. Sargassum appears in 1 tracked Biotech story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sargassum. Shared-story counts are live from our verified record — not editorial picks.
Researchers at Lamont-Doherty Earth Observatory have utilized advanced AI to document a significant global increase in floating macroalgae over the past decade. This discovery, powered by machine learning analysis of satellite imagery, highlights the growing role of 'Blue Biotech' in identifying new biological resources for pharmaceutical and industrial applications.
Source: enn.com · Lamont-Doherty Earth Observatory
Sargassum is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
